Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07809672) titled 'Efficacy and Safety of Stereotactic Body Radiation Therapy for Spinal Metastases With Bilsky Grade 1c-3' on Sept. 3.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital
Condition:
Stereotactic Body Radiation Therapy (SBRT)
Spinal Metastases
Intervention:
Radiation: SBRT
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: September 3, 2026
Target Sample Size: 50
Countries of Recruitment:
China
To know more, ...